Biostatistics Practice Questions

Q: What is the likelihood ratio for positive results?

Sensitivity / (1-Specificity). ### Explanation **Likelihood Ratio for a Positive result (LR+)** is a measure of how much more likely a positive test result is to occur in people with the disease than in people without the disease. It indicates the strength of a diagnostic test. **1. Why Option A is Correct:** The formula for LR+ is the ratio of the probability of a positive test in diseased individuals (**Sensitivity**) to the probability of a positive test in non-diseased individuals (**1 - Specificity**, also known as the False Positive Rate). * **LR+ = Sensitivity / (1 - Specificity)** * A higher LR+ (usually >10) indicates that the test is excellent at "ruling in" a disease. **2. Analysis of Incorrect Options:** * **Option B [Specificity / (1 - Sensitivity)]:** This is an incorrect mathematical arrangement and does not represent a standard epidemiological metric. * **Option C [(1 - Sensitivity) / Specificity]:** This is the formula for the **Likelihood Ratio for a Negative result (LR-)**. It represents the probability of a person with the disease testing negative divided by the probability of a person without the disease testing negative. * **Option D [(1 - Specificity) / Sensitivity]:** This is the reciprocal of LR+ and is not used in clinical practice. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **LR+ > 10:** Strong evidence to rule in the disease. * **LR- < 0.1:** Strong evidence to rule out the disease. * **LR = 1:** The test has no diagnostic value (the post-test probability is the same as the pre-test probability). * Unlike Predictive Values (PPV/NPV), **Likelihood Ratios are independent of disease prevalence**, making them more stable across different clinical settings.

Q: All of the following statements regarding case-control and cohort studies are true, except-

Cohort studies are suitable to investigate 'rare' diseases. In epidemiology, the choice between study designs depends on the frequency of the outcome and the nature of the exposure. **Explanation of the Correct Answer (Option C):** Cohort studies are **not** suitable for investigating rare diseases. In a cohort study, you start with a group of exposed individuals and wait for the disease to develop. If a disease is rare (e.g., a specific rare cancer), you would need to follow an enormous number of people for a very long time to see even a few cases, making it inefficient and expensive. **Case-control studies** are the design of choice for rare diseases because they start with people who already have the disease (cases) and look backward. **Analysis of Incorrect Options:** * **Option A:** In case-control studies, subjects are selected based on the **outcome** (Disease), whereas in cohort studies, they are selected based on **exposure**. This statement is a common point of confusion; however, the question asks for the "false" statement. * **Option B:** Cohort studies are prospective (usually), requiring years of follow-up to observe the development of the disease. Case-control studies are retrospective and can be completed quickly using existing records. * **Option C:** This is the false statement. Cohort studies are ideal for **rare exposures** (e.g., a specific occupational chemical), not rare diseases. * **Option D:** Since cohort studies follow a group over time, researchers can observe the development of multiple different outcomes/diseases resulting from a single exposure. **High-Yield Clinical Pearls for NEET-PG:** * **Rare Disease:** Use Case-Control Study. * **Rare Exposure:** Use Cohort Study. * **Incidence:** Can only be calculated directly from Cohort studies. * **Odds Ratio:** The measure of association for Case-Control. * **Relative Risk (RR) & Attributable Risk (AR):** The measures of association for Cohort studies.

Q: Which of the following study designs does NOT show a cause-to-effect progression?

Case-control study. ### Explanation In epidemiology, the direction of a study refers to the timeline of investigation between the **exposure (cause)** and the **outcome (effect)**. **1. Why Case-Control Study is Correct:** A **Case-control study** is fundamentally **retrospective** in nature. It begins with the **effect** (identifying individuals who already have the disease/cases) and looks backward in time to determine the **cause** (prior exposure). Therefore, it follows an **effect-to-cause** progression, making it the correct answer. **2. Why the Other Options are Incorrect:** * **Cohort Study:** This is the classic **cause-to-effect** design. It starts with a group of exposed and non-exposed individuals (cause) and follows them forward in time to see who develops the disease (effect). * **Randomized Controlled Trial (RCT):** As an experimental study, the investigator intervenes by providing an exposure (e.g., a drug) and monitors the subjects for the outcome. This is a strictly **prospective, cause-to-effect** progression. * **Ecological Study:** While these studies look at populations rather than individuals, they generally analyze whether a suspected risk factor (cause) correlates with disease rates (effect) across different geographical areas or time periods. **3. High-Yield Clinical Pearls for NEET-PG:** * **Directionality:** * Forward (Cause $\rightarrow$ Effect): Cohort, RCT. * Backward (Effect $\rightarrow$ Cause): Case-control. * Ambidirectional: Some Cohort studies. * Snapshot (Simultaneous): Cross-sectional. * **Measure of Association:** Case-control studies use **Odds Ratio (OR)**, while Cohort studies use **Relative Risk (RR)** and **Attributable Risk (AR)**. * **Best for Rare Diseases:** Case-control study. * **Best for Rare Exposures:** Cohort study. * **Gold Standard for Causality:** Randomized Controlled Trial.

Q: To assess if the sample mean is an accurate estimate of the population mean, which statistical measure should be used?

Standard error. ### Explanation The correct answer is **Standard Error (SE)**. **Why Standard Error is correct:** In biostatistics, we rarely study an entire population; instead, we take a sample. The **Standard Error of the Mean (SEM)** measures the precision of the sample mean as an estimate of the true population mean. It quantifies the "sampling error"—the extent to which the sample mean is likely to deviate from the population mean. A smaller SE indicates that the sample mean is a more accurate reflection of the population mean. **Why the other options are incorrect:** * **Geometric Mean:** This is a measure of central tendency used for skewed data or data following a logarithmic distribution (e.g., titers, incubation periods). It does not measure estimation accuracy. * **Range:** This is a measure of dispersion representing the difference between the highest and lowest values in a dataset. It is highly sensitive to outliers and does not relate the sample to the population. * **Standard Deviation (SD):** While often confused with SE, the SD measures the **variability within a single sample** (how much individual observations spread around the sample mean). It describes the data, whereas SE describes the uncertainty of the estimate. **High-Yield Clinical Pearls for NEET-PG:** * **Formula:** $SE = \frac{SD}{\sqrt{n}}$ (where $n$ is the sample size). * As the **sample size ($n$) increases**, the Standard Error decreases, making the estimate more accurate. * **Confidence Intervals (CI):** SE is used to calculate CI. For a 95% CI, the range is $\text{Mean} \pm 1.96 \times SE$. * **Key Distinction:** Use **SD** to describe the distribution of a variable; use **SE** to report the precision of your results.

Q: A researcher wants to evaluate the effect of a new diet regimen on the weight of a group of 10 patients. The researcher records their weight before and after the regimen. Which statistical test will be applicable in this case?

Paired t-test. ### Explanation **Why Paired t-test is Correct:** The **Paired t-test** (also known as the dependent t-test) is used to compare the means of two related groups. In this scenario, the researcher is measuring the **same individuals** (10 patients) at two different time points (**before and after** an intervention). Since the data points are "paired" (each "before" weight corresponds to an "after" weight for the same person), and weight is a **quantitative (numerical) continuous variable**, the paired t-test is the most appropriate statistical tool to determine if the mean difference is statistically significant. **Why Other Options are Incorrect:** * **Chi-square test:** This is used for **qualitative (categorical)** data (e.g., comparing the proportion of smokers vs. non-smokers). It cannot be used for continuous data like weight. * **Unpaired t-test (Student’s t-test):** This is used to compare the means of **two independent groups** (e.g., comparing the weights of 10 men vs. 10 women). In the question, the groups are dependent (same patients). * **ANOVA (Analysis of Variance):** This is used when comparing the means of **three or more independent groups**. Since there are only two sets of observations here, ANOVA is not required. **High-Yield Clinical Pearls for NEET-PG:** * **Parametric Tests:** t-tests and ANOVA assume a normal distribution of data. * **Non-parametric alternative:** If the data in this scenario were not normally distributed, the **Wilcoxon Signed-Rank Test** would be the non-parametric equivalent of the paired t-test. * **Rule of Thumb:** * 1 Group (Before/After) $\rightarrow$ Paired t-test. * 2 Independent Groups $\rightarrow$ Unpaired t-test. * $>2$ Independent Groups $\rightarrow$ ANOVA.

Q: Positive predictive value is most affected by?

Prevalence. **Explanation:** **Positive Predictive Value (PPV)** is the probability that a person who tests positive actually has the disease. Unlike sensitivity and specificity, which are inherent properties of a diagnostic test, predictive values are heavily dependent on the **Prevalence** of the disease in the population being tested. **Why Prevalence is the correct answer:** Mathematically, PPV is calculated as: $TP / (TP + FP)$. As the prevalence of a disease increases, the number of True Positives (TP) increases and the number of False Positives (FP) decreases. Therefore, **PPV is directly proportional to prevalence.** In a high-prevalence setting (e.g., a tertiary care center), a positive test is more likely to be a true positive than in a low-prevalence setting (e.g., general population screening). **Why other options are incorrect:** * **Sensitivity & Specificity:** While these parameters influence the calculation of PPV, they are fixed characteristics of the test itself. They do not fluctuate based on the population. If prevalence changes, PPV changes even if sensitivity and specificity remain constant. * **Relative Risk:** This is a measure of association used in cohort studies to compare the incidence of disease between exposed and non-exposed groups; it does not determine the accuracy or predictive power of a diagnostic test. **High-Yield Clinical Pearls for NEET-PG:** * **PPV vs. Prevalence:** Direct relationship (Prevalence ↑, PPV ↑). * **NPV vs. Prevalence:** Inverse relationship (Prevalence ↑, NPV ↓). * **Screening Strategy:** To maximize PPV, screening should be targeted at "high-risk" groups where prevalence is higher. * **Bayes' Theorem:** This is the mathematical principle that explains how pre-test probability (prevalence) determines post-test probability (predictive value).

Q: Sample size determination depends upon all EXCEPT:

Test statistic value. To determine the appropriate sample size for a study, a researcher must estimate certain parameters **before** the study begins. The **Test Statistic Value** (e.g., the calculated Z-score, t-score, or Chi-square value) is the result of the data analysis performed **after** the study is completed. Therefore, it cannot be used to determine the sample size. ### Why the other options are incorrect: * **Type I Error (Alpha):** This is the probability of rejecting a true null hypothesis (False Positive). A smaller alpha requires a larger sample size to ensure the findings are not due to chance. * **Power (1 - Beta):** Power is the probability of correctly rejecting a false null hypothesis (detecting a real effect). Higher power (e.g., 80% or 90%) requires a larger sample size. * **Expected Parameter Value:** This refers to the estimated prevalence, mean, or effect size based on pilot studies or previous literature. The smaller the expected difference (effect size) between groups, the larger the sample size needed to detect it. ### High-Yield Facts for NEET-PG: * **Precision (d):** Sample size is inversely proportional to the square of precision ($n \propto 1/d^2$). Finer precision requires a larger sample. * **Standard Deviation ($\sigma$):** Sample size is directly proportional to the variance ($n \propto \sigma^2$). More "noisy" or variable data requires more subjects. * **Formula for Qualitative Data:** $n = 4pq/L^2$ (where $p$ = prevalence, $q = 1-p$, and $L$ = allowable error). * **Memory Aid:** To calculate sample size, you need **A-B-C-D**: **A**lpha, **B**eta (Power), **C**linical effect size, and **D**eviation (Standard Deviation).

Question 1

What is the likelihood ratio for positive results?

Accepted Answer

Sensitivity / (1-Specificity)

Answer

Specificity / (1-Sensitivity)

Answer

(1-Sensitivity) / Specificity

Answer

(1-Specificity) / Sensitivity

Question 2

In a village with 180 eligible couples, family planning data of contraceptive method usage is as follows: Sterilization (Vasectomy-3, Tubectomy-8), IUD users-10, Oral pill users-10, Condom users-29. What is the effective Couple Protection Rate (CPR) in the village?

Accepted Answer

25%

Answer

60%

Answer

33%

Answer

10%

Question 3

All of the following statements regarding case-control and cohort studies are true, except-

Accepted Answer

Cohort studies are suitable to investigate 'rare' diseases

Answer

Case-control studies are chosen based on history of 'Exposure'

Answer

Cohort studies require a longer time frame than case-control studies

Answer

Cohort studies yield information about more than one disease

Question 4

What is the Gross Fecundity Rate?

Accepted Answer

Number of female children a woman has during her reproductive period.

Answer

Number of children a woman has during her reproductive period.

Answer

Number of male children a woman has during her reproductive period.

Answer

Total number of live births per 1000 women aged 15-44 years.

Question 5

Which of the following study designs does NOT show a cause-to-effect progression?

Accepted Answer

Case-control study

Answer

Ecological study

Answer

Cohort study

Answer

Randomized controlled trial

Question 6

To assess if the sample mean is an accurate estimate of the population mean, which statistical measure should be used?

Accepted Answer

Standard error

Answer

Geometric mean

Answer

Range

Answer

Standard deviation

Question 7

A researcher wants to evaluate the effect of a new diet regimen on the weight of a group of 10 patients. The researcher records their weight before and after the regimen. Which statistical test will be applicable in this case?

Accepted Answer

Paired t-test

Answer

Chi square test

Answer

Unpaired t-test

Answer

ANOVA

Question 8

Positive predictive value is most affected by?

Accepted Answer

Prevalence

Answer

Sensitivity

Answer

Specificity

Answer

Relative risk

Question 9

Sample size determination depends upon all EXCEPT:

Accepted Answer

Test statistic value

Answer

Type I error

Answer

Power

Answer

Expected parameter value

Question 10

What does reliability mean in research?

Accepted Answer

The consistency of results when a study or measurement is repeated.

Answer

The degree of variation observed in experimental outcomes.

Answer

The degree to which a measurement is accurate.

Answer

The ease with which a test or procedure can be performed.

Biostatistics — MCQs

Biostatistics — MCQs

On this page

Practice by Chapter

Want unlimited practice?